Report an error

Spotted something inaccurate in “IL-17A Inhibitor Secukinumab Shows Promise in Polymyalgia Rheumatica but Mixed Results in Giant Cell Arteritis”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.